PREVALENCE, RISK-FACTORS, AND GENOTYPE DISTRIBUTION OF HEPATITIS-C VIRUS-INFECTION IN THE GENERAL-POPULATION - A COMMUNITY-BASED SURVEY IN SOUTHERN ITALY
V. Guadagnino et al., PREVALENCE, RISK-FACTORS, AND GENOTYPE DISTRIBUTION OF HEPATITIS-C VIRUS-INFECTION IN THE GENERAL-POPULATION - A COMMUNITY-BASED SURVEY IN SOUTHERN ITALY, Hepatology, 26(4), 1997, pp. 1006-1011
In 1996 the prevalence, risk factors, and genotype distribution of hep
atitis C virus (HCV) infection were assessed in the general population
of a town in southern Italy, The sample was selected from the census
by a systematic 1:4 sampling procedure, The participation rate was 96.
6%. Among the 1,352 subjects enrolled, 195 (14.4%) tested reactive to
antibody to HCV (anti-HCV) with enzyme immunoassay (EIA 3), When furth
er tested with recombinant immunoblot assay (RIBA 3), 170 subjects (87
.2%) tested positive, 23 subjects (11.8%) had indeterminate results, a
nd 2 subjects (1%) tested negative. Thus, the overall anti-HCV EIA-pos
itive RIBA-confirmed prevalence was 12.6% (170 of 1,352 subjects) and
increased from 1.3% in subjects younger than 30 years to 33.1% in thos
e greater than or equal to 60 years of age, This latter age group acco
unted for 72.3% of all anti-HCV-positive subjects. Females tested posi
tive more frequently than males (14.1% vs, 10.5%; P <.05). Alanine tra
nsaminase (ALT) concentrations were abnormal in only 4.1% (7/170) of a
nti-HCV EIA-positive RIBA-confirmed subjects, This suggests that ALT s
creening is not useful in the detection of anti-HCV-positive subjects
in a general population, The results of multiple logistic regression a
nalysis showed that an age of less than 45 years, the use of glass syr
inges, and dental therapy were all independent predictors of anti-HCV
positivity, HCV RNA was detected by polymerase chain reaction in 75.9%
of the 195 anti-HCV EIA-positive subjects: in 84.7% (144/170) of the
RIBA-confirmed subjects; in 17.4% (4/23) tested as RIBA indeterminate;
and in neither of the two subjects who tested RIBA negative, HCV type
1b was detected in 75 subjects (50.7%), type 2b in 1 subject (0.7%),
type 2c in 66 subjects (44.6%), type 3a in 4 subjects (2.7%), and type
4 in two subjects (1.3%). These figures differ from those of Italian
patients with chronic liver disease in whom genotype 2 is more rare, N
one of the individuals was infected with more than one genotype, The d
istribution of the two most common HCV viral types (1b and 2c) was not
statistically different in terms of mean age, sex, or risk factors an
d suggests that they may have had a parallel spread in this community.
These findings provide one of the highest overall anti-HCV prevalence
rates in a general population with a likely cohort effect, i.e., decr
eased risk of infection along generations, These observations may indi
cate an epidemic or focus of hepatitis C that occurred several years e
arlier, The majority of anti-HCV-positive subjects in the oldest age g
roup and with no clinical evidence suggests that HCV infection is a ve
ry prolonged and indolent disease.